ROLE OF CD44 AND CD7 MOLECULES IN MEDIATION OF INFLAMMATORY SYNOVITIS

CD44 和 CD7 分子在调节炎性滑膜炎中的作用

基本信息

  • 批准号:
    6201512
  • 负责人:
  • 金额:
    $ 21.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-01 至 2000-08-31
  • 项目状态:
    已结题

项目摘要

Monocyte-T cell interactions are key events in mediation of pathologic immune responses. The broad objectives of this project are to study roles that T cells and monocytes play in rheumatoid arthritis (RA), by focusing on the roles that CD44 isoforms and CD7 deficient T cells play in the pathogenesis of RA and in animal models of inflammatory synovitis. These objectives will be accomplished by the use of peripheral blood (PB), synovial fluid (SF) and synovial tissue from patients with RA, as well as evaluation of a series of novel CD44 and CD7 deficient mouse strains for their ability to develop synovitis when injected with challenge antigens or when bred to mice susceptible to HTLV-l tax transgenic mouse arthritis. Specific aims for Project l are as follows: l) We will study the roles of cytokines in vivo and in vitro in regulation of hyaluronan (HA) binding to CD44 isoforms on monocytes and other synovial cell types in RA, and in tax transgenic mice and mice with collagen-induced arthritis. Study of the cytokines that regulate HA binding (and therefore HA-induced proinflammatory events) in RA and in animal models of RA-like synovitis are critical to development of novel interventional strategies for treatment of RA. 2) We will define the roles of CD44 isoforms in inflammatory synovitis using: a) total CD44 deficient mice. b) mice selectively deficient only in variant CDT forms (but expressing the standard CD44 form. CD44S), and c) mice only expressing select variant CD44 isoforms. CD44 deficient mice will be studied for their response to antigen-induced arthritis (AIA). and bred on a HTLV-l tax transgenic background to determine the effect of CD44 selective and total deficiencies on arthritis in HTLV- l tax transgenic mice. 3) We will study the roles of CD7 deficient T cells and an altered TCR repertoire in mediation of inflammatory synovitis by isolating CD4+, CD7-, CD28- T cells from RA and OA PBMC. SF and synovial tissue and determining the ability of these T cells to produce IFN-gamma and other cytokines/chemokines in response to T cell activation signals, and by studying CD7 deficient mice, in the presence and absence of abnormal T cell receptor (TCR) repertoires in TCR transgenic mice, for their ability to develop arthritis. Taken together these studies will provide insight into the roles that T cells and monocytes play in inflammatory synovitis. and provide new targets for novel therapeutic interventions in RA.
单核细胞- t细胞相互作用是调解病理的关键事件

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Barton F. Haynes其他文献

Human thymic epithelium and T cell development: current issues and future directions.
人类胸腺上皮和 T 细胞发育:当前问题和未来方向。
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Barton F. Haynes
  • 通讯作者:
    Barton F. Haynes
Mechanisms of corticosteroid action on lymphocyte subpopulations. IV. Effects of in vitro hydrocortisone on naturally occuring and mitogen-induced suppressor cells in man.
皮质类固醇对淋巴细胞亚群的作用机制。
  • DOI:
  • 发表时间:
    1979
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Barton F. Haynes;A. Fauci
  • 通讯作者:
    A. Fauci
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture
混合淋巴细胞培养物中人溶细胞性 T 淋巴细胞的表型特征
  • DOI:
  • 发表时间:
    1981
  • 期刊:
  • 影响因子:
    15.3
  • 作者:
    A. Moretta;M. Mingari;Barton F. Haynes;R. Sékaly;L. Moretta;A. Fauci
  • 通讯作者:
    A. Fauci
Early corneal findings in Cogan's syndrome.
科根综合征的早期角膜发现。
  • DOI:
    10.1016/s0161-6420(84)34215-4
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    13.7
  • 作者:
    L. Michael Cobo;Barton F. Haynes
  • 通讯作者:
    Barton F. Haynes
Human Erythrocyte Antigens: II. The <em>In(Lu)</em> Gene Regulates Expression of an Antigen on an 80-Kilodalton Protein of Human Erythrocytes
  • DOI:
    10.1182/blood.v64.3.599.599
  • 发表时间:
    1984-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marilyn J. Telen;Thomas J. Palker;Barton F. Haynes
  • 通讯作者:
    Barton F. Haynes

Barton F. Haynes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Barton F. Haynes', 18)}}的其他基金

Core 1: Administrative Core
核心 1:行政核心
  • 批准号:
    10842499
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Core 1: Administrative Core
核心 1:行政核心
  • 批准号:
    10327520
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Project 1: Panbetacoronavirus vaccines
项目一:泛β冠状病毒疫苗
  • 批准号:
    10842502
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
项目3:核苷修饰mRNA-LNP疫苗平台
  • 批准号:
    10842504
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
项目3:核苷修饰mRNA-LNP疫苗平台
  • 批准号:
    10327525
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Design and Development of a Pan-betacoronavirus Vaccine
泛β冠状病毒疫苗的设计与开发
  • 批准号:
    10842498
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Core 3: Non-human Primate Core
核心3:非人类灵长类核心
  • 批准号:
    10327522
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Project 1: Panbetacoronavirus vaccines
项目一:泛β冠状病毒疫苗
  • 批准号:
    10327523
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Core 3: Non-human Primate Core
核心3:非人类灵长类核心
  • 批准号:
    10842501
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:
Design and Development of a Pan-betacoronavirus Vaccine
泛β冠状病毒疫苗的设计与开发
  • 批准号:
    10327519
  • 财政年份:
    2021
  • 资助金额:
    $ 21.36万
  • 项目类别:

相似海外基金

Inhibition of tumor growth, invasion, and metastasis by targeting CD44 molecule
靶向CD44分子抑制肿瘤生长、侵袭和转移
  • 批准号:
    13557094
  • 财政年份:
    2001
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
  • 批准号:
    2770673
  • 财政年份:
    1997
  • 资助金额:
    $ 21.36万
  • 项目类别:
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
  • 批准号:
    2471152
  • 财政年份:
    1997
  • 资助金额:
    $ 21.36万
  • 项目类别:
Study on CD44 molecule in follicular lymphoma
滤泡性淋巴瘤中CD44分子的研究
  • 批准号:
    07670232
  • 财政年份:
    1995
  • 资助金额:
    $ 21.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了